In this episode, we revisit the controversial Keto-CTA study about cholesterol, and arterial plaque progression. After the authors released some of their raw data, our analysis reveals the study's flaws are far worse than first thought. John breaks down the egregious errors, from published charts that incorrectly cut plaque progression in half, to statistical models that violate their own assumptions, directly contradicting the authors' claims and invalidating their conclusions.